# US 2021/0333194 A1 · Microfluidic chip device for optical force measurements and cell imaging using microfluidic chip configuration and dynamics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0333194 A1
- Document ID: US20210333194A1
- Status: Published application
- Kind: A1
- Application number: 17/237,142
- Filed: 2021-04-22
- Published: 2021-10-28
- Earliest claimed: 2017-12-23
- Assignees: Lumacyte, Inc.
- Applicants: LumaCyte, LLC
- Inventors: Sean Hart; Colin Hebert; Christopher Field; Shweta Krishnan
- Web page: https://patentgrep.com/patent/US20210333194A1

## CPC

- G01N 15/1434: Optical arrangements
- B01L 3/5027: {by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip}
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- G01N 15/147: {the analysis being performed on a sample stream}
- G01N 15/1484: {microstructural devices}
- G01N 21/645: {Specially adapted constructive features of fluorimeters}
- B01L 2200/027: for microfluidic devices
- B01L 2200/0652: Sorting or classification of particles or molecules
- B01L 2300/0654: Lenses; Optical fibres
- B01L 2300/0861: Configuration of multiple channels and/or chambers in a single devices
- B01L 2300/0874: Three dimensional network
- B01L 2400/0418: electro-osmotic flow [EOF]
- B01L 2400/043: magnetic forces
- B01L 2400/0433: vibrational forces
- B01L 2400/0487: fluid pressure, pneumatics
- G01N 2015/1006: {for cytology}
- G01N 2015/1445: {Three-dimensional imaging, imaging in different image planes, e.g. under different angles or at different depths, e.g. by a relative motion of sample and detector, for instance by tomography}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

A microfluidic chip configuration wherein injection occurs in an upwards vertical direction, and fluid vessels are located below the chip in order to minimize particle settling before and at the analysis portion of the chip's channels. The input and fluid flow up through the bottom of the chip, in one aspect using a manifold, which avoids orthogonal re-orientation of fluid dynamics. The contents of the vial are located below the chip and pumped upwards and vertically directly into the first channel of the chip. A long channel extends from the bottom of the chip to near the top of the chip. Then the channel takes a short horizontal turn that nearly negates any influence of cell settling due to gravity and zero flow velocity at the walls. The fluid is pumped up to a horizontal analysis portion that is the highest channel/fluidic point in the chip and thus close to the top of the chip, which results in clearer imaging. A laser may also suspend cells or particles in this channel during analysis which prevents them from settling.

## Claims

### Claim at position 1

-40. (canceled)

### Claim 41

A method for cell or particle analysis, comprising the use of a device wherein the device comprises: the use of a substrate comprising a plurality of channels configured to transport one or more cells or particles, wherein the plurality of channels comprises:
a first channel disposed vertically within the substrate,
a second channel in operable communication with the first channel and disposed horizontally within the substrate,
a third channel in operable communication with the second channel and disposed vertically within the substrate,
and a fourth channel in operable communication with the third channel and disposed horizontally within the substrate;
wherein the first, second, third and fourth channels are disposed in such a manner as to provide a path for movement of the one or more cells or particles through the substrate from the first channel to the second channel to the third channel to the fourth channel, injecting one or more cells or particles into the first channel disposed vertically within the substrate through a bottom horizontal planar surface having an opening to the first channel, to maintain directional and volumetric continuity with the first channel,
wherein the cells or particles are assessed via optical force-based measurements,
wherein the optical force-based measurements are used to yield information pertaining to morphology, motility, binding affinities, binding profiles, effect on other particles, effect on target cells, susceptibility to external forces such as biological, biochemical, chemical, physical, and temperature influences.

### Claim 42 (depends on 41)

The method of claim 41, wherein the assessment comprises a quantitative measurement of variation in the cells or particles and provides predictive or prescriptive analytics.

### Claim 43 (depends on 41)

The method of claim 41, wherein the bottom horizontal planar surface has at least one shorter length from one edge to another edge compared to at least one length from one edge to another edge on a vertical planar surface of the substrate to maintain directional and volumetric continuity with the first channel.

### Claim 44 (depends on 41)

The method of claim 41, wherein the one or more cells or particles are injected into the first channel disposed vertically within the substrate through a bottom horizontal planar surface having an opening to the first channel, wherein the bottom horizontal planar surface has a smaller or equal surface area compared to a surface area on a vertical planar surface of the chip, in a vertical direction to maintain directional and volumetric continuity with the first channel.

### Claim 45 (depends on 41)

The method of claim 41, wherein the first channel comprises an opening disposed at an exterior surface of the substrate and in such a manner as to provide a path for the one or more cells or particles to enter vertically into the substrate and to move vertically within the first channel.

### Claim 46 (depends on 41)

The method of claim 41, further comprising a collimated or focused light source oriented to interact with the cells or particles in the fourth channel.

### Claim 47 (depends on 41)

The method of claim 41, wherein a collimated or focused light source is oriented to propagate in the direction of, opposite the direction of, orthogonal to the direction of, or diagonal to the movement of the one or more cells or particles in the fourth channel.

### Claim 48 (depends on 41)

The method of claim 41, wherein the fourth channel allows for imaging and analysis of the one or more cells or particles during movement of the one or more cells or particles, and from multiple focal planes, angles, and/or orientations by one or more imaging devices.

### Claim 49 (depends on 41)

The method of claim 41, further comprising one or more electrical force, optical force, and/or fluidic force to move the one or more cells or particles in one or more channels.

### Claim 50 (depends on 41)

The method of claim 41, wherein the plurality of channels comprises a fifth channel, which splits into two or more channels or wells to sort cells or particles.

### Claim 51 (depends on 41)

The method of claim 41, further comprising an imaging device selected from at least one of a bright field imager, a light scatter detector, a single wavelength fluorescent detector, a spectroscopic fluorescent detector, a CCD camera, a CMOS camera, a photodiode, a photodiode array (PDA), a spectrometer, a photomultiplier tube or tube array, a photodiode array, a chemiluminescent detector, a bioluminescent detector, a standard Raman spectroscopy detection system, surface enhanced Raman spectroscopy (SERS), coherent antistokes Raman spectroscopy (CARS), and/or coherent stokes Raman spectroscopy (CSRS).

### Claim 52 (depends on 41)

The method of claim 41, wherein laser force cytology (LFC) is used to assess the cells or particles.

### Claim 53 (depends on 52)

The method of claim 52, wherein the use of LFC comprises the combination of microfluidics and light-induced pressure to take measurements comprising optical force, pressure, size, and velocity on a per cell basis.

### Claim 54 (depends on 52)

The method of claim 52, wherein the use of LFC is used to assess characteristics of cells or particles, wherein the characteristics comprise morphology, motility, interaction of the cells or particles with other physiological components, deformability (cytoskeletal changes), or reaction of the biological particles to environmental changes.

### Claim 55 (depends on 41)

The method of claim 41, wherein the assessment of cells or particles comprises the measuring of a complex of one or more cell therapy product cells interacting with one or more target cells or particles.

### Claim 56

A method for assessing cells or particles for use in therapeutic applications, comprising the use of a device wherein the device comprises: the use of a substrate comprising a plurality of channels configured to transport one or more particles, wherein the plurality of channels comprises: a first channel disposed vertically within the substrate, a second channel in operable communication with the first channel and disposed horizontally within the substrate, a third channel in operable communication with the second channel and disposed vertically within the substrate, and a fourth channel in operable communication with the third channel and disposed horizontally within the substrate; wherein the first, second, third and fourth channels are disposed in such a manner as to provide a path for movement of the one or more particles through the substrate from the first channel to the second channel to the third channel to the fourth channel, injecting one or more particles into the first channel disposed vertically within the substrate through a bottom horizontal planar surface having an opening to the first channel, to maintain directional and volumetric continuity with the first channel,
wherein the particles are assessed via laser force cytology (LFC) measurements wherein the LFC measurements are used to yield information pertaining to morphology, motility, binding affinities, binding profiles, effect on other biological particles, effect on target cells, susceptibility to external forces such as biological, biochemical, chemical, physical, and temperature influences.

### Claim 57 (depends on 56)

The method of claim 56, wherein the use of LFC comprises the combination of microfluidics and light-induced pressure to take measurements comprising optical force, pressure, size, and velocity on a per cell basis.

### Claim 58 (depends on 56)

The method of claim 56, wherein the use of LFC is used to assess characteristics of particles, wherein the characteristics comprise morphology, motility, interaction of the particles with other physiological components, deformability (cytoskeletal changes), or reaction of the particles to environmental changes.

### Claim 59 (depends on 56)

The method of claim 56, wherein the assessment of particles comprises the measuring of a complex of one or more cell therapy product cells interacting with one or more target cells or particles.

### Claim 60 (depends on 56)

The method of claim 56, wherein the assessment of particles comprises characterization of cells for efficacy assays, characterization of cells for potency assays, including CAR T and other oncology applications and stem cells, determining the effect of a chemical, bacteria, virus, antimicrobial or antiviral on a specific cell population, and determining the disease state or potential of a research or clinical cell sample.
